Sorry, we were unable to verify the authenticity of this link. If you would like to proceed anyway, click the link below.

https://www.gov.uk/drug-safety-update/denosumab-xgeva-for-giant-cell-tumour-of-bone-risk-of-clinically-significant-hypercalcaemia-following-discontinuation